Cost-effectiveness analysis of nephron sparing options for the management of small renal masses

Journal of Urology

Volumn 185, Issue 5, 2011, Pages 1591-1597

  Chang, Steven L ^a   Cipriano, Lauren E ^b   Harshman, Lauren C ^d   Garber, Alan M ^c,f   Chung, Benjamin I ^e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Stanford University   (United States)

^c STANFORD UNIVERSITY   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^f VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

ablation techniques; cost benefit analysis; decision support techniques; kidney neoplasms; nephrectomy

Indexed keywords

ABLATION THERAPY; AGED; ARTICLE; CASE REPORT; CLINICAL OBSERVATION; COST EFFECTIVENESS ANALYSIS; EARLY INTERVENTION; HEALTH CARE COST; HUMAN; KIDNEY TUMOR; LAPAROSCOPIC SURGERY; NEPHRON SPARING SURGERY; OUTCOME ASSESSMENT; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; QUALITY OF LIFE; SENSITIVITY ANALYSIS; SMALL RENAL MASS; STATISTICAL MODEL;

CARCINOMA, RENAL CELL; CATHETER ABLATION; COST-BENEFIT ANALYSIS; CRYOSURGERY; DECISION SUPPORT TECHNIQUES; FORECASTING; HUMANS; KIDNEY NEOPLASMS; LAPAROSCOPY; MARKOV CHAINS; NEPHRECTOMY; NEPHRONS; QUALITY-ADJUSTED LIFE YEARS; WATCHFUL WAITING;

EID: 79953797449     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.12.100     Document Type: Article

References (29)

1. C.J. Robson, B.M. Churchill, and W. Anderson The results of radical nephrectomy for renal cell carcinoma J Urol 101 1969 297
2. J.M. Hollingsworth, D.C. Miller, and S. Daignault Rising incidence of small renal masses: a need to reassess treatment effect J Natl Cancer Inst 98 2006 1331
3. I.S. Gill, M. Aron, and D.A. Gervais Clinical practice Small renal mass N Engl J Med 362 2010 624
4. B.R. Lane, and I.S. Gill 7-Year oncological outcomes after laparoscopic and open partial nephrectomy J Urol 183 2010 473
5. G.C. Hui, K. Tuncali, and S. Tatli Comparison of percutaneous and surgical approaches to renal tumor ablation: metaanalysis of effectiveness and complication rates J Vasc Interv Radiol 19 2008 1311
6. D.A. Kunkle, and R.G. Uzzo Cryoablation or radiofrequency ablation of the small renal mass: a meta-analysis Cancer 113 2008 2671
7. J.C. Rosales, G. Haramis, and J. Moreno Active surveillance for renal cortical neoplasms J Urol 183 2010 1698
8. S.N. Chawla, P.L. Crispen, and A.L. Hanlon The natural history of observed enhancing renal masses: meta-analysis and review of the world literature J Urol 175 2006 425
9. D.C. Miller, C.S. Saigal, and M. Banerjee Diffusion of surgical innovation among patients with kidney cancer Cancer 112 2008 1708
10. M.C. Weinstein, J.E. Siegel, and M.R. Gold Recommendations of the Panel on Cost-effectiveness in Health and Medicine JAMA 276 1996 1253
11. I. Frank, M.L. Blute, and J.C. Cheville Solid renal tumors: an analysis of pathological features related to tumor size J Urol 170 2003 2217
12. D.A. Kunkle, P.L. Crispen, and D.Y.T. Chen Enhancing renal masses with zero net growth during active surveillance J Urol 177 2007 849
13. P.L. Crispen, R. Viterbo, and S.A. Boorjian Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance Cancer 115 2009 2844
14. P.L. Crispen, R. Viterbo, and E.B. Fox Delayed intervention of sporadic renal masses undergoing active surveillance Cancer 112 2008 1051
15. A.A. Khan, I.S. Shergill, and S. Quereshi Percutaneous needle biopsy for indeterminate renal masses: a national survey of UK consultant urologists BMC Urol 7 2007 10
16. E.J. Hall, and D.J. Brenner Cancer risks from diagnostic radiology Br J Radiol 81 2008 362
17. P.W. Sullivan, and V. Ghushchyan Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative sample Med Decis Making 26 2006 401
18. C. Hogan, J. Lunney, and J. Gabel Medicare beneficiaries' costs of care in the last year of life Health Aff 20 2001 188
19. E. Meara, C. White, and D.M. Cutler Trends in medical spending by age, 1963-2000 Health Aff 23 2004 176
20. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 2009 225
21. K. Lang, N. Danchenko, and K. Gondek The burden of illness associated with renal cell carcinoma in the United States Urol Oncol 25 2007 368
22. J. Thompson Coon, M. Hoyle, and C. Green Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation Health Technol Assess 14 2010 1
23. A.W. Levinson, L.M. Su, and D. Agarwal Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass J Urol 180 2008 499
24. A. Kutikov, B.L. Egleston, and Y.N. Wong Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram J Clin Oncol 28 2010 311
25. P.V. Pandharipande, D.A. Gervais, and P.R. Mueller Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis Radiology 248 2008 169
26. G.W. Torrance, J.E. Siegel, and B.R. Luce Framing and designing the cost-effectiveness analysis M.R. Gold, J.E. Siegel, L.B. Russell, Cost-Effectiveness in Health and Medicine 1996 Oxford University Press New York 54 81
27. C.T. Nguyen, B.R. Lane, and J.H. Kaouk Surgical salvage of renal cell carcinoma recurrence after thermal ablative therapy J Urol 180 2008 104
28. W.C. Huang, E.B. Elkin, and A.S. Levey Partial nephrectomy versus radical nephrectomy in patients with small renal tumorsis there a difference in mortality and cardiovascular outcomes? J Urol 181 2009 55
29. R.L. Fleurence, and C.S. Hollenbeak Rates and probabilities in economic modelling: transformation, translation and appropriate application Pharmacoeconomics 25 2007 3